FibroGen

$33.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.62 (-1.80%) Today
$0.00 (0.00%) As of 9:20 PM UTC after-hours

Why Robinhood?

You can buy or sell FibroGen and other stocks, options, and ETFs commission-free!

About FGEN

FibroGen, Inc Common Stock, also called FibroGen, is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA. The listed name for FGEN is FibroGen, Inc Common Stock.

CEO
Enrique A. Conterno
Employees
531
Headquarters
San Francisco, California
Founded
1993
Market Cap
4.03B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.92M
High Today
$34.82
Low Today
$33.21
Open Price
$34.01
Volume
1.51M
52 Week High
$57.21
52 Week Low
$22.65

FGEN Earnings

-$1.12
-$0.33
$0.47
$1.26
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
-$0.64 per share
Replay Earnings Call

You May Also Like

HBB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure